نتایج جستجو برای: survivin promoter

تعداد نتایج: 93691  

Journal: :Human reproduction 2010
A A V Paupoo Z B Zhu M Wang D T Rein A Starzinski-Powitz D T Curiel

BACKGROUND Novel therapeutic approaches for endometriosis based on molecular strategies may prove to be useful. Conditionally replicative adenoviruses (CRAds) are designed to exploit key differences between target and normal cells. The wild-type adenovirus (Adwt) promoter can be replaced by tissue-specific promoters, allowing viral replication only in target cells. Viral infectivity can be enha...

ژورنال: :کومش 0
حبیب جعفری نژاد habib jaafarinejad cancer research center and department of immunology, faculty of medicine, semnan university of medical sciences, semnan, iranمرکز تحقیقات سرطان، گروه ایمونولوژی، دانشکده پزشکی، دانشگاه علوم پزشکی سمنان، سمنان، ایران نیلوفر غنی زاده niloofar ghanizadeh cancer research center and department of immunology, faculty of medicine, semnan university of medical sciences, semnan, iranمرکز تحقیقات سرطان، گروه ایمونولوژی، دانشکده پزشکی، دانشگاه علوم پزشکی سمنان، سمنان، ایران فرحناز قهرمانفرد farahnaz ghahremanfard internal medicine department, semnan university of medical sciences, semnan, iranگروه پزشکی داخلی، دانشگاه علوم پزشکی سمنان، سمنان، ایران مهدی براتی mehdi barati cancer research center and department of immunology, faculty of medicine, semnan university of medical sciences, semnan, iranمرکز تحقیقات سرطان، گروه ایمونولوژی، دانشکده پزشکی، دانشگاه علوم پزشکی سمنان، سمنان، ایران احسان منوچهری ehsan manouchehri doulabi cancer research center and department of immunology, faculty of medicine, semnan university of medical sciences, semnan, iranمرکز تحقیقات سرطان، گروه ایمونولوژی، دانشکده پزشکی، دانشگاه علوم پزشکی سمنان، سمنان، ایران پرویز کوخایی parviz kokhaei immune and gene therapy lab, cancer centre karolinska, karolinska university hospital, stockholm, swedenآزمایشگاه ایمونولوژی و ژن درمانی، مرکز سرطان کارولینسکا، بیمارستان دانشگاه کارولینسکا، استکهلم، سوئد

هدف: لوسمی لنفوسیتی مزمن یکی از انواع سرطان های خون است که با تکثیر بیش ازحد سلول های b همراه می باشد. این بیماری به طور تقریبی در مردان بالای 50 سال شایع تر است . cll با نقص آپوپتوز در سلول های b همراه است. هدف ما در این مطالعه بررسی بیان پروتئین survivin به عنوان پروتئین مهارکننده آپوپتوز در سلول های تک هسته ای خون محیطی بیماران cll و افراد نرمال تحت تأثیر داروی بربرین در محیط in vitro است. م...

Journal: :Cancer research 2007
Joshua Thomas Tong Liu Murray A Cotter Scott R Florell Kyle Robinette Adrianne N Hanks Douglas Grossman

We previously found the apoptosis inhibitor Survivin to be expressed in melanocytic nevi and melanoma but not in normal melanocytes. To investigate the role of Survivin in melanoma development and progression, we examined the consequences of forced Survivin expression in melanocytes in vivo. Transgenic (Tg) mouse lines (Dct-Survivin) were generated with melanocyte-specific expression of Survivi...

2007
Joshua Thomas Tong Liu Murray A. Cotter Scott R. Florell Kyle Robinette Adrianne N. Hanks Douglas Grossman

We previously found the apoptosis inhibitor Survivin to be expressed in melanocytic nevi and melanoma but not in normal melanocytes. To investigate the role of Survivin in melanoma development and progression, we examined the consequences of forced Survivin expression in melanocytes in vivo . Transgenic (Tg) mouse lines (Dct-Survivin) were generated with melanocyte-specific expression of Surviv...

2013
Feng Ye Bo Zhong Guorong Dan Fan Jiang Yan Sai Jiqing Zhao Huiqin Sun Zhongmin Zou

INTRODUCTION The aim of this study was to construct a lentivirus vector with survivin promoter (pSur)-driven apoptin and test its efficiency in suppressing the growth of tumor cells. MATERIAL AND METHODS Expression cassettes with different fragments of survivin gene promoter (pSur, 161 bp, 272 bp, 990 bp) driving 6XHis-tagged apoptin were constructed to generate recombinant lentivirus, of whi...

Journal: :International journal of oncology 2007
D Wuttig D Kunze S Fuessel M Toma J Stade M Kotzsch M Kappler H Taubert B Schwenzer G Baretton O W Hakenberg A Meye M P Wirth

In order to reduce side effects of survivin-inhibiting anticancer therapies, we determined the expression of the survivin transcripts survivin-wild-type (survivin-wt), survivin-DeltaEx3 (DeltaEx3) and survivin-2B (2B) in cryo-preserved tumor and non-malignant bladder tissues (18 tumor and 22 non-malignant samples, including 17 autologous tissue pairs) by quantitative PCR. Furthermore, we invest...

بابایی, اسماعیل, حسین پورفیضی, محمدعلی, حلیمی, منیره, منتظری, وحید, وندقانونی, سمیه,

Evaluating the Expression of Survivin and Its Splice Variants 2B and ΔEx3 as New Diagnostic Molecular Markers in Thyroid Cancer Vandghanooni S1, Hosseinpour Feizi MA1, Babaei E1,2, Montazeri V3, Halimi M3 1 Dept of Biology, School of Nature Sciences, Tabriz University, Tabriz, Iran 2 Dept of Genetics, Faculty of Basic Sciences, Tarbiat Modarres University, Tehran, Iran 3 Imam Khomeini Hospital,...

2015
MASAYA MINODA TERUYA KAWAMOTO TAKESHI UEHA ETSUKO KAMATA MASAYUKI MORISHITA RISA HARADA MITSUNORI TODA YASUO ONISHI HITOMI HARA MASAHIRO KUROSAKA TOSHIHIRO AKISUE

Survivin is a member of the inhibitor of apoptosis family, which is known to inhibit mitochondrial apoptosis. Survivin is highly expressed in cancers and plays an important role in cancer cell survival, and increased survivin expression is an unfavorable prognostic marker in cancer patients. YM155, a novel small-molecule survivin suppressant, selectively suppresses survivin expression, resultin...

Journal: :Blood 2004
Seiji Fukuda Charlie R Mantel Louis M Pelus

The cyclin-dependent kinase inhibitor p21WAF1/Cip1 and Survivin enhance granulocyte macrophage colony-forming unit (CFU-GM) cell cycle and proliferation and have been implicated as antiapoptotic proteins. We investigated the relationships between p21 and Survivin in primary CFU-GM and c-kit+, lineage-negative (Lin-) cells and demonstrate p21-dependent and -independent pathways whereby Survivin ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید